GLP-1 briefly slows the rate food moves through the gut, which explains the most common side effects: bloating and constipation
NAC, a therapeutic form of the conditionally essential amino acid cysteine, is the rate-limiting reagent for the production of glutathione (Bessems 2001)
Tirzepatide is a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for the treatment of type 2 diabetes mellitus under the brand name Mounjaro and for chronic weight management in adults with obesity or overweight with weight-related comorbidities under the brand name Zepbound
Thorpe, J., Shum, B., Ra, M., Pj, W
For the peptide 20GIPRG s complex, GIPR and G s heterotrimer were co-expressed in High Five cells grown in ESF 921 culture medium (Expression Systems) to a density of 3.2 10 6 cells/mL